title: Restoration of hematopoiesis in a case of myelodysplastic syndrome associated with systemic lupus erythematosus treated with rituximab.
authors.affiliation: Immunology and Allergy, Department of Medical Specialties, School of Medicine, Geneva University Hospitals, Rue Gabrielle-Perret-Gentil 4, 1211, Geneva 14, Switzerland, federico.simonetta@hcuge.ch.
authors.forename: Federico
authors.initials: F
authors.lastname: Simonetta
authors.forename: Magdalena
authors.initials: M
authors.lastname: Posa
authors.forename: Jean
authors.initials: J
authors.lastname: Villard
authors.forename: Alice
authors.initials: A
authors.lastname: Marceau-Renaut
authors.forename: Claude
authors.initials: C
authors.lastname: Preudhomme
authors.forename: Kaveh
authors.initials: K
authors.lastname: Samii
authors.forename: Carlo
authors.initials: C
authors.lastname: Chizzolini
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000494:pharmacology / Q000627:therapeutic use*; D005260:Female; D006410:Hematopoiesis / Q000187:drug effects*; D006801:Humans; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D009190:Myelodysplastic Syndromes / Q000097:blood / Q000175:diagnosis / Q000188:drug therapy*; D000069283:Rituximab; D016896:Treatment Outcome
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D000970:Antineoplastic Agents; D000069283:Rituximab